Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Exelixis Inc (NASDAQ:EXEL)

5.73
Delayed Data
As of Jul 31
 +0.19 / +3.43%
Today’s Change
1.26
Today|||52-Week Range
6.38
+297.92%
Year-to-Date

Today’s Trading

Previous close5.54
Today’s open5.52
Day’s range5.51 - 6.12
Volume7,412,202
Average volume (3 months)5,620,476
Market cap$1.3B
Dividend yield--
Data as of 3:59pm ET, 07/31/2015

Growth & Valuation

Earnings growth (last year)-3.76%
Earnings growth (this year)+38.28%
Earnings growth (next 5 years)0.00%
Revenue growth (last year)-19.87%
P/E ratioNM
Price/Sales11.14
Price/Book--

Competitors

 Today’s
change
Today’s
% change
FGENFibroGen Inc+0.33+1.44%
ARIAARIAD Pharmaceutical...+0.31+3.95%
NXTMNxStage Medical Inc+0.29+2.07%
LXRXLexicon Pharmaceutic...-0.05-0.59%
Data as of 3:59pm ET, 07/31/2015

Financials

Next reporting dateAugust 12, 2015
EPS forecast (this quarter)-$0.21
Annual revenue (last year)$25.1M
Annual profit (last year)-$268.5M
Net profit margin-1,069.42%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Michael M. Morrissey
Chief Financial Officer &
Executive Vice President
Christopher J. Senner
Corporate headquarters
South San Francisco, California

Forecasts